Preclinical Studies on Neurobehavioral and Neuromuscular Effects of Cocaine Hydrolase Gene Therapy in Mice

[1]  S. Brimijoin,et al.  Gene Transfer of Mutant Mouse Cholinesterase Provides High Lifetime Expression and Reduced Cocaine Responses with No Evident Toxicity , 2013, PloS one.

[2]  S. Brimijoin,et al.  Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage. , 2013, Chemico-biological interactions.

[3]  S. Brimijoin,et al.  Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice. , 2013, Chemico-biological interactions.

[4]  David Baltimore,et al.  Antibody-based Protection Against HIV Infection by Vectored ImmunoProphylaxis , 2011, Nature.

[5]  H. Ehrlich,et al.  Biochemical, molecular and preclinical characterization of a double‐virus‐reduced human butyrylcholinesterase preparation designed for clinical use , 2011, Vox sanguinis.

[6]  C. Zhan,et al.  Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine. , 2010, Chemico-biological interactions.

[7]  N. Bornstein,et al.  Serum Cholinesterase Activities Distinguish between Stroke Patients and Controls and Predict 12-Month Mortality , 2010, Molecular medicine.

[8]  D. Ingram,et al.  Development of a water-escape motivated version of the Stone T-maze for mice , 2010, Neuroscience.

[9]  Fang Zheng,et al.  Most efficient cocaine hydrolase designed by virtual screening of transition states. , 2008, Journal of the American Chemical Society.

[10]  K. Bailey,et al.  Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  E. Duysen,et al.  The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency , 2008, Journal of Pharmacology and Experimental Therapeutics.

[12]  David T. Curiel,et al.  Engineering targeted viral vectors for gene therapy , 2007, Nature Reviews Genetics.

[13]  R. Kotin,et al.  Recombinant adeno‐associated virus vector for gene transfer to the transplanted rat heart , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  E. Duysen,et al.  Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. , 2007, Toxicology.

[15]  O. Lockridge,et al.  A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[16]  O. Lockridge,et al.  Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India , 2006, Pharmacogenetics and genomics.

[17]  B. P. Doctor,et al.  Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. , 2005, Chemico-biological interactions.

[18]  B. P. Doctor,et al.  Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. , 2005, Chemico-biological interactions.

[19]  S. Brimijoin,et al.  Radiometric solvent-partitioning assay for screening cocaine hydrolases and measuring cocaine levels in milligram tissue samples. , 2002, Analytical biochemistry.

[20]  Kae Nakamura,et al.  Central mechanisms of motor skill learning , 2002, Current Opinion in Neurobiology.

[21]  In-Hoo Kim,et al.  Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Brimijoin,et al.  Abundant Tissue Butyrylcholinesterase and Its Possible Function in the Acetylcholinesterase Knockout Mouse , 2000, Journal of neurochemistry.

[23]  M. Salpeter,et al.  125I-labeled fasciculin 2: A new tool for quantitation of acetylcholinesterase densities at synaptic sites by EM-autoradiography , 1998, Journal of Neuroscience Methods.

[24]  Richard S. J. Frackowiak,et al.  Anatomy of motor learning. II. Subcortical structures and learning by trial and error. , 1997, Journal of neurophysiology.

[25]  M. Rudnicki,et al.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Jankovic,et al.  Parkinson's Disease and Movement Disorders , 1988 .

[27]  R. L. Russell,et al.  A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. , 1975, Analytical biochemistry.

[28]  B. P. Doctor,et al.  Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX. , 2011, Biochemical pharmacology.

[29]  Ann Silver,et al.  The biology of cholinesterases , 1974 .